Available Guidance and Best Practices for Conducting Forced Degradation Studies

Author(s)Dan W. Reynolds, PhD, Karen M. Alsante, PhD, Kevin L. Facchine, PhD

Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.

External Link - article-9668.pdf

Articles in this issue

almost 24 years ago

Article

Using Earned-Value Analysis to Better Manage Projects

almost 24 years ago

Article

Microbial Bioburden on Oral Solid Dosage Forms

almost 24 years ago

Article

Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part I

almost 24 years ago

Article

Modernizing Pharmaceutical Manufacturing

almost 24 years ago

Article

The Role of Computational Fluid Dynamics in the Pharmaceutical Industry

almost 24 years ago

Article

Outsourcing Outlook

almost 24 years ago

Article

Effect of Formulation and Process Variables on Matrix Erosion and Drug Release from a Multiunit Erosion Matrix of a Poorly Soluble Drug

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!